Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#111 / 131 Total
VTRU - Vitru Ltd - Stock Price Chart
TickerVTRU [NASD]
CompanyVitru Ltd
CountryBrazil
IndustryEducation & Training Services
Market Cap439.79MEPS (ttm)0.60
P/E21.75EPS this Y44.51%
Forward P/E4.33EPS next Y44.57%
PEG1.52EPS past 5Y-
P/S1.12EPS next 5Y14.30%
P/B0.96EPS Q/Q-374.32%
Dividend1.29%Sales Q/Q25.28%
Insider Own58.90%Inst Own32.50%
Insider Trans0.00%Inst Trans1.33%
Short Float0.08%EarningsMar 21/a
Analyst Recom1.00Target Price25.35
Avg Volume5.24K52W Range9.80 - 18.05
Vitru Ltd. operates as a pure-player in the post-secondary digital education market. The firm provides a complete pedagogical ecosystem focused on hybrid distance learning experience for undergraduates and continuing education students. It operates through the following segments: Digital education undergraduate courses, Continuing education courses and On-campus undergraduate courses. The Digital education undergraduate courses segment offers educational content and support via internet and mobile devices and its portfolio of courses is composed mainly of pedagogy, business administration, accounting, physical education, vocational education, engineering and health-related courses. The Continuing education courses segment offers continuing education courses predominantly in pedagogy, finance and business and it offers courses in different versions like in a hybrid model, 100% online and on-campus. The On-campus undergraduate courses segment offers traditional on-campus undergraduate courses, including those that are currently not allowed to be offered through digital education, such as law and health-related courses, and others such as business administration, accounting, physical education, and engineering . The company was founded on March 5, 2020 and is headquartered in Florianopolis, Brazil.
UPC - Universe Pharmaceuticals INC - Stock Price Chart
TickerUPC [NASD]
CompanyUniverse Pharmaceuticals INC
CountryChina
IndustryDrug Manufacturers - Specialty & Generic
Market Cap7.96MEPS (ttm)-1.70
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.25EPS next 5Y-
P/B0.20EPS Q/Q47.96%
Dividend-Sales Q/Q-13.17%
Insider Own57.05%Inst Own0.18%
Insider Trans0.00%Inst Trans-97.13%
Short Float0.25%EarningsJan 30/a
Analyst Recom-Target Price-
Avg Volume99.67K52W Range0.75 - 5.88
Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.
CYCC - Cyclacel Pharmaceuticals Inc - Stock Price Chart
TickerCYCC [NASD]
CompanyCyclacel Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap1.99MEPS (ttm)-27.02
P/E-EPS this Y49.98%
Forward P/E-EPS next Y-
PEG-EPS past 5Y32.13%
P/S4.75EPS next 5Y-
P/B2.63EPS Q/Q30.27%
Dividend-Sales Q/Q-
Insider Own8.89%Inst Own7.12%
Insider Trans7.27%Inst Trans-
Short Float3.20%EarningsMar 19/a
Analyst Recom1.00Target Price11.00
Avg Volume108.39K52W Range1.41 - 13.20
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rombotis Spiro GeorgePresident and CEODec 21 '23Buy3.316,07020,12268,658Dec 26 04:05 PM
McBarron PaulSee RemarksDec 21 '23Buy3.311,8866,25233,378Dec 26 04:05 PM
TWG - Top Wealth Group Holding Limited - Stock Price Chart
TickerTWG [NASD]
CompanyTop Wealth Group Holding Limited
CountryHong Kong
IndustryFood Distribution
Market Cap43.79MEPS (ttm)0.08
P/E17.98EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.71EPS next 5Y-
P/B-EPS Q/Q53.50%
Dividend-Sales Q/Q88.70%
Insider Own69.52%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume6.98M52W Range1.35 - 5.50
Top Wealth Group Holding Limited, through its subsidiaries, provides caviar and caviar-based gourmet products in Hong Kong and internationally. The company also trades in caviars; and offers its products under the Imperial Cristal Caviar brand name. It serves food and beverage related distributors. The company was founded in 2009 and is based in Sai Wan, Hong Kong. Top Wealth Group Holding Limited operates as a subsidiary of Winwin Development Group Limited.
NOTV - Inotiv Inc - Stock Price Chart
TickerNOTV [NASD]
CompanyInotiv Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap104.45MEPS (ttm)-1.29
P/E-EPS this Y89.76%
Forward P/E-EPS next Y33.33%
PEG-EPS past 5Y-184.24%
P/S0.18EPS next 5Y-
P/B0.41EPS Q/Q82.49%
Dividend-Sales Q/Q10.38%
Insider Own10.83%Inst Own18.88%
Insider Trans2.21%Inst Trans-9.15%
Short Float5.09%EarningsFeb 07/a
Analyst Recom1.00Target Price15.50
Avg Volume469.21K52W Range1.61 - 11.42
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Beattie John GregoryChief Operating OfficerDec 14 '23Buy3.1247,966149,836111,761Dec 15 05:33 PM
Garrett MichaelChief Commercial OfficerDec 14 '23Buy2.835,00014,14516,467Dec 15 05:33 PM
HTZ - Hertz Global Holdings Inc. - Stock Price Chart
TickerHTZ [NASD]
CompanyHertz Global Holdings Inc.
CountryUSA
IndustryRental & Leasing Services
Market Cap628.17MEPS (ttm)0.62
P/E7.16EPS this Y-376.00%
Forward P/E14.46EPS next Y120.89%
PEG-EPS past 5Y-
P/S0.07EPS next 5Y-
P/B0.48EPS Q/Q-200.49%
Dividend-Sales Q/Q1.61%
Insider Own4.10%Inst Own-
Insider Trans0.00%Inst Trans-6.56%
Short Float17.38%EarningsApr 25/b
Analyst Recom3.33Target Price6.29
Avg Volume5.68M52W Range4.35 - 19.36
Apr-26-24Downgrade BofA Securities Neutral → Underperform $9 → $3
Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leef EricEVP, Chief HR OfficerMay 08 '23Sale16.231,94631,58455,723May 08 04:21 PM
SIFY - Sify Technologies Limited ADR - Stock Price Chart
TickerSIFY [NASD]
CompanySify Technologies Limited ADR
CountryIndia
IndustryTelecom Services
Market Cap217.58MEPS (ttm)-
P/E-EPS this Y-0.07%
Forward P/E29.76EPS next Y300.00%
PEG-EPS past 5Y-
P/S0.51EPS next 5Y-
P/B1.18EPS Q/Q-
Dividend-Sales Q/Q7.73%
Insider Own-Inst Own0.62%
Insider Trans-Inst Trans-13.62%
Short Float0.02%EarningsApr 22/a
Analyst Recom1.00Target Price3.93
Avg Volume77.79K52W Range1.07 - 3.37
Sify Technologies Ltd. engages in the provision of integrated Internet, network, and electronic commerce services in India. It operates through the following segments: Network-centric Services, and Data Center-centric Information Technology Services. The Network-centric Services segment includes domestic data, international data wholesale voice, and network managed services. The Data Center-centric Information Technology Services segment comprises of data center; cloud and managed; technology integration, and applications integration services. The company was founded on December 12, 1995 and is headquartered in Chennai, India.
LNSR - LENSAR Inc - Stock Price Chart
TickerLNSR [NASD]
CompanyLENSAR Inc
CountryUSA
IndustryMedical Devices
Market Cap36.94MEPS (ttm)-1.34
P/E-EPS this Y20.84%
Forward P/E-EPS next Y18.22%
PEG-EPS past 5Y0.14%
P/S0.88EPS next 5Y-
P/B1.10EPS Q/Q-45.46%
Dividend-Sales Q/Q18.31%
Insider Own17.82%Inst Own41.95%
Insider Trans0.14%Inst Trans-0.49%
Short Float0.73%EarningsMar 04/b
Analyst Recom1.00Target Price8.00
Avg Volume41.14K52W Range1.80 - 5.30
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Winer Gary MDirectorNov 22 '23Buy2.1030063053,345Nov 27 07:30 PM
Winer Gary MDirectorNov 16 '23Buy2.121,0002,12553,045Nov 17 06:18 PM
Winer Gary MDirectorNov 15 '23Buy2.155001,07552,045Nov 17 06:18 PM
Winer Gary MDirectorNov 10 '23Buy2.131,0002,13551,545Nov 14 07:31 PM
Winer Gary MDirectorAug 11 '23Buy3.607052,53850,545Aug 14 07:01 PM
ADTX - Aditxt Inc - Stock Price Chart
TickerADTX [NASD]
CompanyAditxt Inc
CountryUSA
IndustryBiotechnology
Market Cap4.68MEPS (ttm)-146.46
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y45.26%
P/S7.21EPS next 5Y-
P/B0.20EPS Q/Q88.86%
Dividend-Sales Q/Q-56.20%
Insider Own0.07%Inst Own1.36%
Insider Trans0.00%Inst Trans-
Short Float10.83%Earnings-
Analyst Recom1.00Target Price3.70
Avg Volume372.09K52W Range2.14 - 68.08
Apr-02-24 08:30AM Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD) (Business Wire) +5.97%
07:30AM Appili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc. (GlobeNewswire)
Mar-27-24 08:36AM Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 (PR Newswire)
Mar-20-24 08:54AM Evofem Negotiates Improved Rebate for Hormone-Free 'In the Moment' Contraceptive PHEXXI with Medi-Cal (PR Newswire) +5.25%
Mar-07-24 07:54AM For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy (PR Newswire) +13.51%
Feb-01-24 08:00AM Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023 (PR Newswire)
Jan-30-24 08:30AM Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap and NeuroEEG for Telehealth and Tele-neurology Applications (Business Wire)
Jan-08-24 08:30AM Aditxt, Inc.s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.s Proprietary Mitomic Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million (Business Wire)
Jan-05-24 08:30AM Aditxt Announces Closing of $6.0 Million Private Placement Priced At-The-Market under Nasdaq Rules (Business Wire)
Jan-02-24 08:30AM Aditxt, Inc. Regains Compliance with Nasdaq Stockholders Equity Requirement (Business Wire) -27.60%
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Richmond, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BNP PARIBAS SECURITIES CORPReduced under 10% ownerSep 07 '23Sale33.2320,800691,14022,342Sep 07 05:41 PM
EQ - Equillium Inc - Stock Price Chart
TickerEQ [NASD]
CompanyEquillium Inc
CountryUSA
IndustryBiotechnology
Market Cap60.28MEPS (ttm)-0.38
P/E-EPS this Y88.82%
Forward P/E-EPS next Y-876.47%
PEG-EPS past 5Y18.79%
P/S1.67EPS next 5Y-
P/B2.67EPS Q/Q-182.53%
Dividend-Sales Q/Q-41.55%
Insider Own51.18%Inst Own7.46%
Insider Trans0.00%Inst Trans2.51%
Short Float2.31%EarningsMar 25/a
Analyst Recom1.00Target Price6.75
Avg Volume367.09K52W Range0.45 - 3.25
Equillium, Inc. engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March, 2017 and is headquartered in La Jolla, CA.
17891011121314